JSM 2004 - Toronto

JSM Activity #112

This is the preliminary program for the 2004 Joint Statistical Meetings in Toronto, Canada. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2004); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2004 Program page
Legend: = Applied Session, = Theme Session, = Presenter
FRY = Fairmont Royal York, ICH = InterContinental Hotel, TCC = Metro Toronto Convention Center
Add To My Program
112 Theme Session Mon, 8/9/04, 10:30 AM - 12:20 PM TCC-714 A
Survival Analysis - Contributed - Papers
Biopharmaceutical Section
Chair(s): Shuguang Huang, Eli Lilly and Company
     10:35 AM   A Joint Longitudinal and Survival Model that Flexibly Incorporates Nonproportional Hazards Treatment Effects — Daniel L. Gillen, University of Chicago; Sebastien Haneuse, University of Washington
     10:50 AM   Tests for Time to a Favorable Event — ; Nicole O. Stouffer, Purdue Pharma LP
     11:05 AM   A New Testing Approach for Comparing the Overall Homogeneity of Survival Curves — Hongkun Wang, University of Rochester; Xun Lin, Pfizer Global Research and Development
     11:20 AM   A Simple Hybrid Variance Estimator for the Kaplan-Meier Survival Function — Craig B. Borkowf, Centers for Disease Control and Prevention
     11:35 AM   A Novel Approach of Estimation for Additive Rate Regression Models with Parametric Underlying Failure-time Distributions — M. Brent McHenry, University of Pittsburgh; Stuart R. Lipsitz, Medical University of South Carolina; Debajyoti Sinha, Medical University of South Carolina
     11:50 AM   Estimation of Lag Time between Onset of and Death from an Occult Tumor — Hojin Moon, U.S. Food and Drug Administration; Hongshik Ahn, SUNY, Stony Brook; Ralph L. Kodell, U.S. Food and Drug Administration
     12:05 PM   Alternative Approach for Estimating Tumor Response Rate — Xiaolong Luo, Johnson & Johnson Pharmaceutical R&D, LLC
 

JSM 2004 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2004